GHX Announces 2008 Best In Class Award Winners
...ly/Sci Products** Metal/Plastic/Paper Products Care Line Inc. Microbiology Reagents/Supplies biomerieux SA Needles & Syringes NovoNordisk Ostomy Coloplast** Parenteral B Brau...ExonHit Reports Proof-of-Concept in Breast Cancer Diagnostic Using its SpliceArray(TM) Platform
...'s disease and cancers. ExonHit has a balanced investment strategy with internal development programs and strategic collaborations, in particular with biomerieux and Allergan. ExonHit is headquartered in Paris, France and has a U.S. facility in Gaithersburg, Maryland. The Company is listed on Alternext o...Foreign Medical Devices are in High Demand in Russia
...Zeneca - Boehringer Ingelheim - GlaxoSmithKline - Novartis - Dade Behring - Ortho-Clinical Diagnostics - Beckman Coulter - biomerieux Sa - St. Jude Medical - Sorin - Biotronik - Kazanskiy Zavod Meditsinskoy - Kazanskiy Mediko-Instrumentalniy - Uralsky Priboros...ExonHit's EHT 0202 Counters Scopolamine's Detrimental Effects on Cognition in Humans
... These products are marketed worldwide in conjunction with Agilent and Affymetrix. In the field of diagnostics, ExonHit has a major collaboration with biomerieux to develop completely novel predictive blood-based cancer diagnostics, which could play a key role in improving the treatment of breast cancer and oth...Laboratory Customers Name bioMerieux 'Top Of Class' for Microbiology
DURHAM, N.C., Dec. 17 /PRNewswire/ -- In a recent customer satisfaction survey of over 30,000 readers of ADVANCE for Administrators of the Laboratory, bioMerieux was voted by its customers as the "Top Of Class" winner for the microbiology category. The top-level lab managers and pathologists who s...ExonHit and bioMerieux Amend Their Strategic Partnership
PARIS, January 9 /PRNewswire-FirstCall/ -- ExonHit Therapeutics, a drug and diagnostic discovery company, announced today that it has signed an amendment to its strategic partnership with bioMerieux in the field of cancer diagnostics. Under the terms of the amendment, ExonHit will gain commerc...ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results
...t in the clinical trial market in Q4 2009, and in the clinical diagnostic market in a second step through a partnering model. In February 2009, biomerieux and ExonHit Therapeutics agreed on new research and development plans as part of their existing collaboration to develop blood-based cancer detection ...bioMerieux Introduces Surveillance Tool to Fight Healthcare-Associated Infections
...ard, executive vice president and general manager, biomerieux North America. "ICNet Systems, Inc. offers our cus... found at http://www.icnetplc.com . About biomerieux Advancing Diagnostics to Improve Public Hea...illion with 84% of sales outside of France. biomerieux provides diagnostic solutions (reagents, instrumen...ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies
... These products are marketed worldwide in conjunction with Agilent and Affymetrix. In the field of diagnostics, ExonHit has a major collaboration with biomerieux to develop completely novel predictive blood-based cancer diagnostics, which could play a key role in improving the treatment of breast cancer and oth...U.S. Clinicians Indicate a Strong Need for New Tools to Combat Sepsis
...ntibiotics DURHAM, N.C., July 24 /PRNewswire/ -- biomerieux recently conducted two surveys, fielded during con...lion with 84 percent of sales outside of France. biomerieux provides diagnostic solutions (reagents, instrumen... agri-food, pharmaceutical, and cosmetic products. biomerieux is listed on the NYSE Euronext Paris market (Code:...